Effects of Pulses Through the Gut Microbiome and Bioavailability of Bioactive Compounds
LEGUMINIBUS
Discovering the Effects of Pulses Through the Gut Microbiome and Bioavailability of Bioactive Compounds
1 other identifier
interventional
84
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the effects of replacing red meat with pulses, on cardiometabolic health and gut microbiome in individuals with unhealthy habits and sedentary lifestyles at high risk for cardiovascular diseases. The main questions it aims to answer are:
- be assigned to either the Pulses Diet (PulD) group or the Plant Proteins Diet (PPD) group or the Habitual diet (HabD) group;
- follow their habitual diet (HabD) or the prescribed dietary plan designed on individual habitual diet to be isocaloric and isoprotein but replacing red meat with pulses (PulD group) or a combination of pulses and plant-based meat substitutes (PPD group);
- keep their physical activity levels unchanged during the entire intervention period;
- be required to complete 7-day food diaries and associated questionnaires on appetite, along with additional questionnaires related to physical activity levels, overall well-being, mood, sleep quality, stool frequency and consistency at each nutritional intervention time-point. Researchers will compare PulD, PPD, and HabD to assess if the dietary interventions have an impact on cardiometabolic health and gut microbiome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedStudy Start
First participant enrolled
January 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2024
CompletedJanuary 12, 2024
January 1, 2024
9 months
August 13, 2023
January 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in fasting total cholesterol concentration
Measure of serum total cholesterol concentration (mg/dL serum)
2 months
Changes in plasma TMAO concentration
Measure of plasma TMAO concentration (μmol/L plasma)
2 months
Secondary Outcomes (43)
Changes in faecal microbiome
2 months
Changes in urinary TMAO concentration
2 months
Changes in urinary polyphenols concentration
2 months
Changes in urinary urolithin concentration
2 months
Changes in urinary betaine concentration
2 months
- +38 more secondary outcomes
Study Arms (3)
Pulses Diet (PulD)
EXPERIMENTALSubjects will follow a Pulses-enriched diet for 2 months.
Plant Proteins Diet (PPD)
EXPERIMENTALSubjects will follow a Plant protein-enriched diet for 2 months.
Habitual Diet (HabD)
ACTIVE COMPARATORSubjects will follow a habitual diet for two months.
Interventions
Subjects in the PulD group will be assigned a personalized diet prepared based on their own eating habits as established by 7-day food diary recalls. Energy values of habitual diets will be kept unchanged during the PulD intervention. The diet will be characterized by isocaloric and isoprotein substitutions, replacing habitual servings of red meat or processed meat with servings of pulses.
Subjects in the PPD group will be assigned a personalized diet prepared based on their own eating habits as established by 7-day food diary recalls. Energy values of habitual diets will be kept unchanged during the PPD intervention. The diet will be characterized by isocaloric and isoprotein substitutions, replacing habitual servings of red meat or processed meat with a mixture of pulses and plant-based meat substitutes.
Control subjects will not change their habitual diet during intervention. All subjects will be requested not to change physical activity levels during the 8 week intervention period.
Eligibility Criteria
You may qualify if:
- men and women aged 18-65;
- ≤ BMI ≤ 35 kg/m2;
- habitual diet characterized by ≥ 3 medium servings of fresh red meat or processed meat (equivalent to a portion weight of 100g of fresh meat and 50g of cured meats);
- habitual diet without probiotics, functional foods, and/or any type of food supplements;
- low level of physical activity (sedentary lifestyle);
- signing the informed consent form and expressing consent for the processing of personal data.
You may not qualify if:
- Food allergies and intolerances, such as celiac disease, lactose intolerance, and others;
- Gastrointestinal disorders of any kind;
- Significant medical conditions;
- Pregnancy or breastfeeding;
- Hypertriglyceridemia (Triglycerides \> 200 mg/dL);
- Hypercholesterolemia (Cholesterol \> 200 mg/dL);
- Diabetes (Blood glucose ≥ 126 mg/dL);
- Hypertension (Blood pressure \> 140/90 mm Hg);
- Weight loss ≥ 3 kg in the past 2 months prior to the study;
- Use of any medication at enrollment and in the 2 months prior to the study;
- Regular diet rich in fruits and vegetables;
- Consumption of alcohol equivalent to or exceeding 3 glasses of wine per day;
- Concurrent participation in other clinical trials.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Paola Vitaglionelead
Study Sites (1)
Department of Agricultural Sciences, Federico II University
Portici, 80055, Italy
Related Publications (2)
Crimarco A, Springfield S, Petlura C, Streaty T, Cunanan K, Lee J, Fielding-Singh P, Carter MM, Topf MA, Wastyk HC, Sonnenburg ED, Sonnenburg JL, Gardner CD. A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood-Meat Eating Alternative Trial (SWAP-MEAT). Am J Clin Nutr. 2020 Nov 11;112(5):1188-1199. doi: 10.1093/ajcn/nqaa203.
PMID: 32780794RESULTMeslier V, Laiola M, Roager HM, De Filippis F, Roume H, Quinquis B, Giacco R, Mennella I, Ferracane R, Pons N, Pasolli E, Rivellese A, Dragsted LO, Vitaglione P, Ehrlich SD, Ercolini D. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut. 2020 Jul;69(7):1258-1268. doi: 10.1136/gutjnl-2019-320438. Epub 2020 Feb 19.
PMID: 32075887RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Paola Vitaglione, Professor
Department of Agricultural Sciences, Federico II University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
August 13, 2023
First Posted
August 21, 2023
Study Start
January 10, 2024
Primary Completion
October 16, 2024
Study Completion
October 16, 2024
Last Updated
January 12, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Data will become available immediately after the publications of the results with no end date.
- Access Criteria
- Metagenomic reads generated in this study will be available (without conditions of reuse) at the European Nucleotide Archive (ENA) in European Bioinformatics Institute (EBI), by using a specific accession number. The clinical data will be shared with any researcher who will ask the corresponding author by providing a methodologically sound proposal.
All individual participant data that underlie the results reported in the publication will be shared after deidentification